“The Safety and Efficacy of Roflumilast Cream 0.15% and 0.05% in Atopic Dermatitis: Phase 2 Proof-of-Concept Study”. 2020. SKIN The Journal of Cutaneous Medicine 4 (6): s93. https://doi.org/10.25251/skin.4.supp.93.